Illuminating B7-H3 Protein Dimerization and Function

阐明 B7-H3 蛋白二聚化和功能

基本信息

项目摘要

SUMMARY/ABSTRACT Understanding the protein-protein interactions (PPIs) between the B7-family of immune regulatory proteins and their cognate binding partners on the T-cell have led to a new era in cancer treatment, where checkpoint blockade by monoclonal antibodies inhibiting CTLA-4 and PD-1 on the T-cell has revolutionized immunotherapy. These PPIs provide both stimulatory secondary signals to promote and sustain T cell responses, and they also contribute to negative secondary signals that downregulate T cell responses. PD-L1, PD-L2, B7-H3, B7-H4 and HHLA-2 can be expressed on non-hematopoetic cells and tumors, but the role of temporal, as well as, spatial differences in ligand expression and their contributions to pathogenic and protective immune responses have not been fully elucidated. Many B7 family members, similar to other families of cell surface signaling proteins, are known to exist as dimers, related to their signaling state. Thus, characterization of B7 family interactions and oligomerization is essential to understanding the molecular mechanisms by which they alter the cancer cell to confer an oncogenic phenotype. From a candidate gene approach, an interesting and novel target protein is B7- H3, a member of the B7-family, which is overexpressed on the surface of many solid tumors. This proposal aims to develop a bioluminescence-based, sequential resonance energy transfer (BLI-SRET) reporter of PPIs that can be used to define structural features that contribute to B7-H3 dimerization and oligomerization and determine the mechanism of how these interactions promote cancer cell survival and immune evasion. In aim 1, I will develop a BLI-SRET system which can distinguish dimeric or multimeric protein complexes in a spatiotemporal manner. This system will allow us to understand how signals are integrated at a molecular level through protein dimerization and oligomerization, and provide a platform to aid characterizing those interactions that contribute to pathogenesis. In aim 2, I will test the hypothesis that defined regions of B7-H3 contribute to protein clustering and that ablation of these interacting domains will disrupt protein function, both intracellularly and extracellularly, through the complemented immune synapse. As each interacting domain may serve a different downstream function, understanding the similar or different mechanisms that regulate B7-H3-driven tumorigenesis may better enable pathway-specific targeting of therapeutics and improve our understanding of B7-H3 oligomerization and how this relates to its function. The research proposed herein will support my training and development as an independent and productive cancer biologist, allowing me to gain a greater understanding of assay development, genetically encoded optical biosensors, and the application of these tools to understand complex biological processes. Using the longstanding practical expertise and development of optical imaging agents in the Piwnica- Worms group and my detailed understanding of KRAS protein clustering as it relates to cancer development, we aim to develop this system that will allow us to better understand how signals are integrated at a molecular level, and use it to aid in developing therapeutics to target the B7-family of oncogenic immune regulatory proteins.
总结/摘要 了解免疫调节蛋白B7家族与免疫调节蛋白之间的蛋白质-蛋白质相互作用(PPI) 它们在T细胞上的同源结合伴侣已经引领了癌症治疗的新时代, 通过单克隆抗体抑制T细胞上的CTLA-4和PD-1,彻底改变了免疫疗法。这些 PPI提供刺激性次级信号以促进和维持T细胞应答,并且它们还 有助于负次级信号,下调T细胞反应。PD-L1、PD-L2、B7-H3、B7-H4和 HHLA-2可在非造血细胞和肿瘤上表达,但其作用时间和空间上均不相同。 配体表达的差异及其对致病性和保护性免疫应答的贡献, 尚未完全阐明。许多B7家族成员,类似于细胞表面信号蛋白的其他家族, 已知以二聚体形式存在,这与它们的信号状态有关。因此,B7家族相互作用的表征和 寡聚化对于理解它们改变癌细胞的分子机制是必不可少的, 赋予致癌表型。从候选基因的方法,一个有趣的和新的靶蛋白是B7- H3是B7家族的成员,在许多实体瘤的表面过表达。这项建议旨在 开发基于生物发光的PPI序列共振能量转移(BLI-SRET)报告基因, 可用于定义有助于B7-H3二聚化和低聚化的结构特征,并确定 这些相互作用如何促进癌细胞存活和免疫逃避的机制。在目标1中,我将 开发一个BLI-SRET系统,可以区分二聚体或多聚体蛋白质复合物在时空 方式这个系统将使我们能够理解信号是如何通过蛋白质在分子水平上整合的 二聚和低聚,并提供一个平台,以帮助表征那些相互作用,有助于 发病机制在目标2中,我将检验B7-H3的特定区域有助于蛋白质聚类的假设 并且这些相互作用结构域的消融将破坏蛋白质功能,包括细胞内和细胞外, 通过互补的免疫突触由于每个相互作用的结构域可以服务于不同的下游 功能,了解调节B7-H3驱动的肿瘤发生的相似或不同机制可能更好 实现治疗剂的途径特异性靶向,并提高我们对B7-H3寡聚化的理解, 这与它的功能有什么关系。本文提出的研究将支持我的培训和发展, 独立和富有成效的癌症生物学家,使我能够更好地了解检测开发, 遗传编码光学生物传感器,以及这些工具在理解复杂生物学中的应用 流程.利用Piwnica长期以来的实践专长和光学成像剂的发展, 蠕虫小组和我对KRAS蛋白质聚类的详细理解,因为它与癌症的发展有关,我们 旨在开发这个系统,使我们能够更好地了解信号是如何在分子水平上整合的, 并利用它来帮助开发针对致癌免疫调节蛋白B7家族的治疗方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Margie Nicole Sutton其他文献

Margie Nicole Sutton的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Margie Nicole Sutton', 18)}}的其他基金

Illuminating B7-H3 Protein Dimerization and Function
阐明 B7-H3 蛋白二聚化和功能
  • 批准号:
    10179335
  • 财政年份:
    2020
  • 资助金额:
    $ 7.17万
  • 项目类别:

相似海外基金

Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
  • 批准号:
    502556
  • 财政年份:
    2024
  • 资助金额:
    $ 7.17万
  • 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
  • 批准号:
    10659303
  • 财政年份:
    2023
  • 资助金额:
    $ 7.17万
  • 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
  • 批准号:
    10674405
  • 财政年份:
    2023
  • 资助金额:
    $ 7.17万
  • 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
  • 批准号:
    10758772
  • 财政年份:
    2023
  • 资助金额:
    $ 7.17万
  • 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
  • 批准号:
    10676499
  • 财政年份:
    2023
  • 资助金额:
    $ 7.17万
  • 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
  • 批准号:
    2748611
  • 财政年份:
    2022
  • 资助金额:
    $ 7.17万
  • 项目类别:
    Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
  • 批准号:
    10532032
  • 财政年份:
    2022
  • 资助金额:
    $ 7.17万
  • 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
  • 批准号:
    22K05630
  • 财政年份:
    2022
  • 资助金额:
    $ 7.17万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
  • 批准号:
    10525070
  • 财政年份:
    2022
  • 资助金额:
    $ 7.17万
  • 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
  • 批准号:
    10689017
  • 财政年份:
    2022
  • 资助金额:
    $ 7.17万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了